Neil Kumar

Dr. Neil Kumar, Ph.D., is the CEO and Founder of BridgeBio Pharma, Inc. a company working to create life-altering medicines that target well-characterized genetic diseases at their source. Before founding BridgeBio in 2015, Dr. Kumar was a principal at Third Rock Ventures, supporting and managing portfolio companies, while also focusing on new company formation and due diligence. During his time at Third Rock, Dr. Kumar served as the interim vice president of business development and operations for MyoKardia. Prior to joining Third Rock, Dr. Kumar was an associate principal at McKinsey & Company, where he developed strategies for pharmaceutical and medical device companies and helped lead McKinsey’s personalized medicine efforts. Dr. Kumar holds B.S. and M.S. degrees in chemical engineering from Stanford University. He received his Ph.D. in chemical engineering from the Massachusetts Institute of Technology. He also a Member of the Board for the Global Genes organization.